Induction of inducible nitric oxide synthase in hepatocytes isolated from rats with ischemia-reperfusion injury. 2004

H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
Department of Surgery, Kansai Medical University, Osaka, Japan.

BACKGROUND Recent evidence indicates that nitric oxide (NO) has a crucial role in hepatic ischemia-reperfusion (I/R) injury. However, little is known about how I/R influences the gene expression of inducible nitric oxide synthase (iNOS) in hepatocytes. Under inflammatory conditions, we compared the induction of iNOS in hepatocytes isolated from normal and I/R-treated rats. METHODS Hepatocytes were isolated using the collagenase perfusion method from rats treated with I/R (30-minute ischemia of middle and left lobes, followed by 3-hour reperfusion) or sham operation (control): Primary cultures of rat hepatocytes were incubated with an inflammatory cytokine, interleukin-1beta (IL-1beta), to compare the iNOS induction/NO production between the 2 groups. RESULTS Both control and I/R groups had no production of nitrite (a stable metabolite of NO) in the absence of IL-1beta. In the control group, IL-1beta stimulated dose- and time-dependent production of NO. The I/R group showed more than 2-fold increased levels of NO production. Western and Northern blot analyses revealed that the I/R group also showed increased levels of iNOS protein and its messenger RNA. CONCLUSIONS These results suggest that I/R directly affects the inducibility of the iNOS gene in hepatocytes by IL-1beta. Increased NO may be associated with protective or toxic effects in hepatic I/R injury.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008297 Male Males
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D015971 Gene Expression Regulation, Enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. Enzymologic Gene Expression Regulation,Regulation of Gene Expression, Enzymologic,Regulation, Gene Expression, Enzymologic
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
November 1996, Experimental eye research,
H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
March 2002, Kidney international,
H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
February 2013, Canadian journal of surgery. Journal canadien de chirurgie,
H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
May 2018, Sleep & breathing = Schlaf & Atmung,
H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
September 2007, The Journal of trauma,
H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
May 2011, Anesthesiology,
H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
January 1999, Life sciences,
H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
November 2000, Transplantation proceedings,
H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
March 2005, Acta pharmacologica Sinica,
H Yanagida, and M Kaibori, and M Yamada, and K Habara, and N Yokoigawa, and A-H Kwon, and Y Kamiyama, and T Okumura
September 1999, The American journal of physiology,
Copied contents to your clipboard!